Factors Associated with Post-vaccination Immunity Against COVID-19 in Benin
Open Access
- 15 January 2026
- journal article
- Published by Science Publishing Group in World Journal of Public Health
- Vol. 11 (1) , 11-19
Abstract
Introduction: Vaccination remains the primary strategy against COVID-19. However, data may not reflect actual population immunity. This study aims to determine the seroprevalence of post-vaccination immunity against COVID-19 in Benin and identify associated factors. Methods: A cross- sectional descriptive and analytical study was conducted from April to September 2023 in 21 hospital centers across Benin's twelve departments and included 3802. Post-vaccination immunity was defined by the presence of anti-SARS-CoV-2 Spike IgG antibodies and the absence of anti-NCP IgG antibodies, using the Euroimmun ELISA test. Data were analyzed using STATA software with multivariate logistics regression. Results: Seroprevalence of post-vaccination immunity was 41.56%. In multivariate analysis, factors associated with this immunity were age (adjusted OR=1.56; 95% CI [1.09-2.59]), residence within the former sanitary cordon (aOR=1.34; 95% CI [1.14-3.01]), history of hypertension/cardiovascular disease (aOR=3.25; 95% CI [1.41-4.63]), and history of diabetes (aOR=2.73; 95% CI [1.89-3.93]). Conclusion: Post-vaccination immunity is higher among vulnerable groups (elderly, comorbidities) and those in strategic urban zones, reflecting the prioritization of vaccination campaigns. Recommendations are proposed to target younger populations and rural areas to strengthen collective immunity.Keywords
This publication has 30 references indexed in Scilit:
- Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in SwedenThe Lancet Infectious Diseases, 2022
- Methods for Counting COVID-19 Deaths in US States and TerritoriesInternational Journal of Infectious Diseases, 2022
- Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective studyThe Lancet Regional Health - Europe, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communicationsThe Lancet Regional Health - Europe, 2021
- Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 studyThe Lancet Respiratory Medicine, 2021
- Africa’s low COVID-19 mortality rate: A paradox?International Journal of Infectious Diseases, 2021
- SARS-CoV-2 seroprevalence in Spain – Authors' replyThe Lancet, 2020
- Determinants of COVID-19 vaccine acceptance in the USeClinicalMedicine, 2020
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases, 2020